Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Giuseppe Derosa, Angela D’Angelo, Arianna Vanelli & Pamela Maffioli. (2020) An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia. Diabetes, Metabolic Syndrome and Obesity 13, pages 653-661.
Read now
Read now
Safieh Firouzi, Mahsa Malekahmadi, Majid Ghayour-Mobarhan, Gordon Ferns & Hamid Reza Rahimi. (2018) Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action. Diabetes, Metabolic Syndrome and Obesity 11, pages 699-705.
Read now
Read now
Francesco Di Pierro, Pietro Putignano, Tarcisio Ferrara, Carmela Raiola, Giuliana Rapacioli & Nicola Villanova. (2017) Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia. Clinical Pharmacology: Advances and Applications 9, pages 1-7.
Read now
Read now
Zhiyou Cai, Chuanling Wang & Wenming Yang. (2016) Role of berberine in Alzheimer’s disease. Neuropsychiatric Disease and Treatment 12, pages 2509-2520.
Read now
Read now
Francesco Di Pierro, Iaele Bellone, Giuliana Rapacioli & Pietro Putignano. (2015) Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes, Metabolic Syndrome and Obesity 8, pages 89-96.
Read now
Read now
Yuhong Zhang, Lijiao Xu, Jingjun Qiu, Minglong Sun, Chunmei Xia, Zhiqiang Zhou & Tong Liu. (2014) Provenance variations in berberine content of Phellodendron amurense, a rare and endangered medicinal plant grown in Northeast China. Scandinavian Journal of Forest Research 29:8, pages 725-733.
Read now
Read now
Francesco Di Pierro, Pietro Putignano, Nicola Villanova, Luca Montesi, Simona Moscatiello & Giulio Marchesini. (2013) Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clinical Pharmacology: Advances and Applications 5, pages 167-174.
Read now
Read now
Giuseppe Derosa, Aldo Bonaventura, Lucio Bianchi, Davide Romano, Angela D'Angelo, Elena Fogari & Pamela Maffioli. (2013)
Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients. Expert Opinion on Biological Therapy 13:11, pages 1495-1506.
Read now
Read now
Paramjit S Tappia, Yan–Jun Xu & Naranjan S Dhalla. (2013) Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies. Clinical Lipidology 8:3, pages 345-359.
Read now
Read now
Articles from other publishers (51)
Mehran Shayganfard. (2023) Berberine: Is it a Promising Agent for Mental Disorders Treatment?. Current Molecular Pharmacology 16:3, pages 307-320.
Crossref
Crossref
Xiaofang Guo, Xiwen Xiong, Lijun Zhao, Genshen Zhong & Xiaofei Zhu. 2023. Anti-Aging Pharmacology. Anti-Aging Pharmacology
305
327
.
Firdaus Jahan, Sahir Sultan Alvi & Mohammad Hayatul Islam. (2022) Berberis aristata and its secondary metabolites: Insights into nutraceutical and therapeutical applications. Pharmacological Research - Modern Chinese Medicine 5, pages 100184.
Crossref
Crossref
Wenting Xie, Fugui Su, Guizhong Wang, Zichong Peng, Yaomin Xu, Yi Zhang, Ningning Xu, Kaijian Hou, Zhuping Hu, Yan Chen & Rongping Chen. (2022) Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology 13.
Crossref
Crossref
Giuseppe Derosa, Angela D'Angelo & Pamela Maffioli. (2022) The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literature. Phytotherapy Research 36:10, pages 3709-3765.
Crossref
Crossref
Anna Koperska, Agnieszka Wesołek, Małgorzata Moszak & Monika Szulińska. (2022) Berberine in Non-Alcoholic Fatty Liver Disease—A Review. Nutrients 14:17, pages 3459.
Crossref
Crossref
Fatemeh Mohtashaminia, Mohammad Reza Amini, Fatemeh Sheikhhossein, Kurosh Djafarian & Sakineh Shab-Bidar. (2022) Effects berberine–silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Clinical Nutrition ESPEN 49, pages 181-186.
Crossref
Crossref
Vittoria Infantino, Antonella Riva, Giovanna Petrangolini, Pietro Allegrini, Simone Perna, Giancarlo Iannello, Gabriella Peroni, Clara Gasparri & Mariangela Rondanelli. (2022) The Use of Berberine in Diabetes and Metabolic Syndrome: Two Sides of
the Same Coin. A Bibliometric Analysis. Current Nutrition & Food Science 18:3, pages 240-247.
Crossref
Crossref
Jean M. Bokelmann. 2022. Medicinal Herbs in Primary Care. Medicinal Herbs in Primary Care
495
509
.
Michalina Mróz, Katarzyna Pastusiak & Paweł Bogdański. (2021) Potencjalne możliwości wykorzystania berberyny w przeciwdziałaniu insulinooporności i w cukrzycy typu 2. Postępy Higieny i Medycyny Doświadczalnej 75:1, pages 790-801.
Crossref
Crossref
Mariangela Rondanelli, Antonella Riva, Giovanna Petrangolini, Pietro Allegrini, Attilio Giacosa, Teresa Fazia, Luisa Bernardinelli, Clara Gasparri, Gabriella Peroni & Simone Perna. (2021) Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest–Post-Test Explanatory Study. Nutrients 13:10, pages 3665.
Crossref
Crossref
Sapana Bansod, Mohd Aslam Saifi & Chandraiah Godugu. (2021) Molecular updates on berberine in liver diseases: Bench to bedside. Phytotherapy Research 35:10, pages 5459-5476.
Crossref
Crossref
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra & Marco Cerbón. (2021) Silymarin is an ally against insulin resistance: A review. Annals of Hepatology 23, pages 100255.
Crossref
Crossref
Bhanu Malhotra, Giriraj T. Kulkarni, Neerupma Dhiman, D.D. Joshi, Subhash Chander, Amit Kharkwal, Arun K. Sharma & Harsha Kharkwal. (2021) Recent advances on Berberis aristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system. Journal of Herbal Medicine 27, pages 100433.
Crossref
Crossref
Aram Khashayar, Zahra Bahari, Moradipour Elliyeh & Maedeh Ghasemi. (2021) Therapeutic Effects of Berberine in Metabolic Diseases and Diabetes Mellitus. Revista Brasileira de Farmacognosia 31:3, pages 272-281.
Crossref
Crossref
Juan M. León-MartínezEsperanza Martínez-AbundisManuel González-OrtizKarina G. Pérez-Rubio. (2021) Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial. Journal of Medicinal Food 24:2, pages 111-115.
Crossref
Crossref
Xinmei Xu, Huan Yi, Jiasi Wu, Tingting Kuang, Jing Zhang, Qi Li, Huan Du, Tong Xu, Guihua Jiang & Gang Fan. (2021) Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomedicine & Pharmacotherapy 133, pages 110984.
Crossref
Crossref
Farzaneh Barzkar, Hamid Reza Baradaran, Mohammad Ebrahim Khamseh, Roya Vesal Azad, Jalil Koohpayehzadeh & Yousef Moradi. (2020) Medicinal plants in the adjunctive treatment of patients with type-1 diabetes: a systematic review of randomized clinical trials. Journal of Diabetes & Metabolic Disorders 19:2, pages 1917-1929.
Crossref
Crossref
Francesco Di Pierro, Alexander Bertuccioli, Rosanna Giuberti, Mariella Saponara & Leandro Ivaldi. (2020) Role of a berberine-based nutritional supplement in reducing diarrhea in subjects with functional gastrointestinal disorders. Minerva Gastroenterologica e Dietologica 66:1.
Crossref
Crossref
Amira R. Amin, Rami B. Kassab, Ahmed E. Abdel Moneim & Hatem K. Amin. (2020)
Comparison Among Garlic, Berberine, Resveratrol,
Hibiscus sabdariffa
, Genus
Zizyphus
, Hesperidin, Red Beetroot,
Catha edulis
,
Portulaca oleracea
, and Mulberry Leaves in the Treatment of Hypertension and Type 2 DM: A Comprehensive Review
. Natural Product Communications 15:4, pages 1934578X2092162.
Crossref
Crossref
Tarun Belwal, Aarti Bisht, Hari Prasad Devkota, Hammad Ullah, Haroon Khan, Aseesh Pandey, Indra Dutt Bhatt & Javier Echeverría. (2020) Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Frontiers in Pharmacology 11.
Crossref
Crossref
Alexander BertuccioliSara MoricoliStefano AmatoriMarco Bruno Luigi RocchiGiorgia ViciDavide Sisti. (2020) Berberine and Dyslipidemia: Different Applications and Biopharmaceutical Formulations Without Statin-Like Molecules—A Meta-Analysis. Journal of Medicinal Food 23:2, pages 101-113.
Crossref
Crossref
Elnaz Rezaeiamiri, Roodabeh Bahramsoltani & Roja Rahimi. (2020) Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: A review of clinical trials. Clinical Nutrition 39:2, pages 331-342.
Crossref
Crossref
M. Rondanelli, Vittoria Infantino, A. Riva, G. Petrangolini, M. A. Faliva, G. Peroni, M. Naso, M. Nichetti, D. Spadaccini, C. Gasparri & S. Perna. (2020) Polycystic ovary syndrome management: a review of the possible amazing role of berberine. Archives of Gynecology and Obstetrics 301:1, pages 53-60.
Crossref
Crossref
Shahid AkbarShahid Akbar. 2020. Handbook of 200 Medicinal Plants. Handbook of 200 Medicinal Plants
421
428
.
Anurag K. Singh, Santosh K. Singh, Manmath K. Nandi, Gaurav Mishra, Anand Maurya, Arati Rai, Gopal K. Rai, Rajendra Awasthi, Bhupesh Sharma & Giriraj T. Kulkarni. (2019) Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease. Central Nervous System Agents in Medicinal Chemistry 19:3, pages 154-170.
Crossref
Crossref
Mirko Koziolek, Stefano Alcaro, Patrick Augustijns, Abdul W. Basit, Michael Grimm, Bart Hens, Caroline L. Hoad, Philipp Jedamzik, Christine M. Madla, Marc Maliepaard, Luca Marciani, Annalisa Maruca, Neil Parrott, Petr Pávek, Christopher J.H. Porter, Christos Reppas, Diana van Riet-Nales, Jari Rubbens, Marina Statelova, Natalie L. Trevaskis, Kateřina Valentová, Maria Vertzoni, Dubravka Vitali Čepo & Maura Corsetti. (2019) The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group. European Journal of Pharmaceutical Sciences 134, pages 31-59.
Crossref
Crossref
Federica Fogacci, Davide Grassi, Manfredi Rizzo & Arrigo F.G. Cicero. (2019) Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials. Phytotherapy Research 33:4, pages 862-870.
Crossref
Crossref
Golnaz Azami, Kim Lam Soh, Shariff-Ghazali Sazlina, Md. Said Salmiah, Afra Khosravi, Sanaz Aazami & Reza Valizadeh. (2019) The Effect of Depression on Poor Glycemic Control in Adults with Type 2 Diabetes: The Mediating Roles of Self-Efficacy and Self-Management Behaviors. Dubai Diabetes and Endocrinology Journal 25:3-4, pages 80-89.
Crossref
Crossref
Xueling Ma, Zhongjun Chen, Le Wang, Gesheng Wang, Zihui Wang, XiaoBo Dong, Binyu Wen & Zhichen Zhang. (2018) The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine. Frontiers in Pharmacology 9.
Crossref
Crossref
Yanwen Wang & Jeffrey A. Zidichouski. (2018) Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Cholesterol 2018, pages 1-17.
Crossref
Crossref
Fatemeh Lazavi, Parvin Mirmiran, Golbon Sohrab, Omid Nikpayam, Pooneh Angoorani & Mehdi Hedayati. (2018) The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: A randomized clinical trial. Complementary Therapies in Clinical Practice 31, pages 170-174.
Crossref
Crossref
Homeira Rashidi, Foroogh Namjoyan, Zahra Mehraban, Mehrnoosh Zakerkish, Seyed Bahman Ghaderian & Seyed Mahmoud Latifi. (2018) The Effects of Active Ingredients of Barberry Root (Berberine) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients. Jundishapur Journal of Natural Pharmaceutical Products In Press:In Press.
Crossref
Crossref
MY Zhang, YY Yu, SF Wang, Q Zhang, HW Wu, JY Wei, W Yang, SY Li & HJ Yang. (2017)
Cardiotoxicity evaluation of nine alkaloids from
Rhizoma Coptis
. Human & Experimental Toxicology 37:2, pages 185-195.
Crossref
Crossref
Adriano José Maia Chaves Filho, Camila Nayane Carvalho Lima, Silvânia Maria Mendes Vasconcelos, David Freitas de Lucena, Michael Maes & Danielle Macedo. (2018) IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity. Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, pages 234-249.
Crossref
Crossref
Giuseppe Derosa, Angela D'Angelo & Pamela Maffioli. (2016) The role of a fixed Berberis aristata/Silybum marianum combination in the treatment of type 1 diabetes mellitus. Clinical Nutrition 35:5, pages 1091-1095.
Crossref
Crossref
Feng-Hao Geng, Guo-Hua Li, Xing Zhang, Peng Zhang, Ming-Qing Dong, Zhi-Jing Zhao, Yuan Zhang, Ling Dong & Feng Gao. (2016) Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats. British Journal of Pharmacology 173:10, pages 1569-1579.
Crossref
Crossref
Chang-Shun Liu, Yu-Rong Zheng, Ying-Feng Zhang & Xiao-Ying Long. (2016) Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 109, pages 274-282.
Crossref
Crossref
Angela Pirillo & Alberico Luigi Catapano. (2015) Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies. Atherosclerosis 243:2, pages 449-461.
Crossref
Crossref
Giuseppina Guarino, Teresa Della Corte, Morena Sofia, Lucia Carbone, Giampiero Marino, Emilia Martedì & Sandro Gentile. (2015) Metabolic effects of the association Berberis aristata/Silybum marianum: a preliminary double-blind, placebo-controlled study in obese patients with type 2 diabetes. Nutrafoods 14:4, pages 181-188.
Crossref
Crossref
Angelo Maria Patti, Khalid Al-Rasadi, Niki Katsiki, Yajnavalka Banerjee, Dragana Nikolic, Luca Vanella, Rosaria Vincenza Giglio, Valeria Ausilia Giannone, Giuseppe Montalto & Manfredi Rizzo. (2015)
Effect of a Natural Supplement Containing
Curcuma Longa
, Guggul, and Chlorogenic Acid in Patients With Metabolic Syndrome
. Angiology 66:9, pages 856-861.
Crossref
Crossref
Wenguang ChangLi ChenGrant M. Hatch. (2015) Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochemistry and Cell Biology 93:5, pages 479-486.
Crossref
Crossref
Jing Yao, WeiJia Kong & JianDong Jiang. (2014) Learning from berberine: Treating chronic diseases through multiple targets. Science China Life Sciences 58:9, pages 854-859.
Crossref
Crossref
Giuseppe Derosa, Davide Romano, Angela D'Angelo & Pamela Maffioli. (2015) Berberis aristata combined with Silybum marianum on lipid profile in patients not tolerating statins at high doses. Atherosclerosis 239:1, pages 87-92.
Crossref
Crossref
Gregory Oxenkrug. 2015. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease. Tryptophan Metabolism: Implications for Biological Processes, Health and Disease
173
195
.
Eric YarnellKathy Abascal. (2014) Herbs for Diabetes: Update—Part 1. Alternative and Complementary Therapies 20:6, pages 328-333.
Crossref
Crossref
Elisa Nicoloso Simões Pires, Rudimar Luiz Frozza, Juliana Bender Hoppe, Bruna de Melo Menezes & Christianne Gazzana Salbego. (2014) Berberine was neuroprotective against an in vitro model of brain ischemia: Survival and apoptosis pathways involved. Brain Research 1557, pages 26-33.
Crossref
Crossref
Francesco Di Pierro. (2014) Roles of Chemical Complexity and Evolutionary Theory in Some Hepatic and Intestinal Enzymatic Systems in Chemical Reproducibility and Clinical Efficiency of Herbal Derivatives. The Scientific World Journal 2014, pages 1-12.
Crossref
Crossref
Raffaele Marfella, Nunzia D’Onofrio, Ivana Sirangelo, Maria Rosaria Rizzo, Maria Carmela Capoluongo, Luigi Servillo, Giuseppe Paolisso & Maria Luisa Balestrieri. 2014. Diabetes: Oxidative Stress and Dietary Antioxidants. Diabetes: Oxidative Stress and Dietary Antioxidants
145
156
.
Gregory Oxenkrug. (2013) Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways. Molecular Neurobiology 48:2, pages 294-301.
Crossref
Crossref
Zhijun Wang, Jeffrey Wang & Patrick Chan. (2013) Treating Type 2 Diabetes Mellitus with Traditional Chinese and Indian Medicinal Herbs. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-17.
Crossref
Crossref